SLC2A1 and cancer: And from the results of the correlation analysis between the expression level of SLC2A1 and the CNV level of SLC2A1, they were significantly correlated in 19 cancers (Figure 3G), including LIHC, KIRC and UCEC, where previous DNA promoter methylation failed to explain the abnormal expression of SLC2A1.